Katleen Van Uytfanghe

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Alcohol Consumption

High Resolution Mass Spectrometry

Gas Chromatography

Top Venues

Drug testing and analysis

Archives of toxicology

Clinical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Liesl K Janssens, Katleen Van Uytfanghe, Jeffrey B Williams, Kirk W Hering, Donna M Iula, Christophe Pol Stove
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs. Archives of toxicology 98 (8) (2024)
Liesl K Janssens, Katleen Van Uytfanghe, Jeffrey B Williams, Kirk W Hering, Donna M Iula, Christophe Pol Stove
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs. Archives of toxicology 98 (8) (2024)
Liesl K Janssens, Katleen Van Uytfanghe, Jeffrey B Williams, Kirk W Hering, Donna M Iula, Christophe Pol Stove
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs. Archives of toxicology (2024)
Caitlyn Norman, Marie H Deventer, Olivia Dremann, Robert Reid, Katleen Van Uytfanghe, Claude Guillou, Inge M J Vinckier, Niamh Nic Daéid, Alex J Krotulski, Christophe Pol Stove
In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid. Drug testing and analysis (2023)
Katleen Van Uytfanghe, Christophe Pol Stove
Increasing Confidence in a Phosphatidylethanol 16:0/18:1 Cutoff at 20 ng/mL to Support Abstinence or Minor Intake of Alcohol. Clinical chemistry (2023)
Mauro Panteghini, Federica Braga, Johanna E Camara, Vincent Delatour, Katleen Van Uytfanghe, Hubert W Vesper, Tianjiao Zhang, null null
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM). Clinical chemistry 67 (12) (2022)
Marie H Deventer, Katleen Van Uytfanghe, Inge M J Vinckier, Fabiano Reniero, Claude Guillou, Christophe Pol Stove
A new cannabinoid receptor 1 selective agonist evading the 2021 "China ban": ADB-FUBIATA. Drug testing and analysis 14 (9) (2022)
Marie H Deventer, Katleen Van Uytfanghe, Inge M J Vinckier, Fabiano Reniero, Claude Guillou, Christophe Pol Stove
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug testing and analysis 14 (9) (2022)
Marc Luginbühl, Friedrich M Wurst, Frederike Stöth, Wolfgang Weinmann, Christophe Pol Stove, Katleen Van Uytfanghe
Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel). Drug testing and analysis 14 (10) (2022)
Peter Blanckaert, Annelies Cannaert, Katleen Van Uytfanghe, Fabian Hulpia, Eric Deconinck, Serge Van Calenbergh, Christophe Pol Stove
Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene. Drug testing and analysis 12 (4) (2020)